Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03778177 · ClinicalTrials.gov registry record · NA
Neurophysiologic Signatures of Trigeminal Neuralgia Pain
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03778177 is a NA study that has completed, run by University of Florida. The registered enrollment target is 61 participants.
The verdict
NCT03778177, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
Trigeminal neuralgia (TN) is an idiopathic pain disorder that is characterized by episodic attacks of intense facial pain, described as paroxysms of stabbing, electric, or explosive pain, and lasting for a few seconds or longer, often producing a tic-like facial movement, and can occur up to hundreds of times per day. This pain is known to be one of the worst pain conditions that a patient can suffer and has been called the "suicide disease". Given the severity of this disorder, determining the cause becomes essential for finding a cure. This project will study the cause of TN using a translational approach, which means the research project will be completed in both humans and animals. The investigators hypothesize that there are specific areas of the brain and spinal cord that will provide a "signature" center of activity. The study team will use state of the art magnetic resonance imaging (MRI) machines and other non-invasive brain activity measurements, including electroencephalography (EEG) to locate these centers in people with TN before and after their pain has started. Recent studies have investigated the effects of transcranial electrical stimulation (tES) for pain control. Transcranial electrical stimulation (tES) includes transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS). This approach is important because identifying similar regions neural activity will allow for us to study novel therapies in search of the cure for TN and this study has thus both basic and clinical neuroscience significance.
Interventions
- PROCEDURE transcranial electrical brain stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03778177
The ClinicalTrials.gov registry entry for NCT03778177 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial electrical brain stimulation is the first listed.
NCT03778177 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03778177 about?
NCT03778177 is a clinical study titled "Neurophysiologic Signatures of Trigeminal Neuralgia Pain". Trigeminal neuralgia (TN) is an idiopathic pain disorder that is characterized by episodic attacks of intense facial pain, described as paroxysms of stabbing, electric, or explosive pain, and lasting for a few seconds or longer, often producing a tic-like facial movement, and can occur up to hundred...
What is the current status of trial NCT03778177?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2019-02-01. Estimated completion is 2022-05-12.
What interventions are being tested in trial NCT03778177?
The interventions under investigation include: transcranial electrical brain stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT03778177?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.